Empyrean Capital Partners’s Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 IPOD.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding IPOD.WS
AC
LCM
ICM
LA
PWAM
TP
MF
MCM
RCM
Empyrean Capital Partners's IPOD.WS Position: Q1 2021 in Review
Empyrean Capital Partners sold out of Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (IPOD.WS) in Q1 2021, closing a stake of 375,000 shares — an estimated $1.39M sold.
Empyrean Capital Partners first reported a position in IPOD.WS in Q4 2020 and held it in 1 quarter. The position peaked at $1.39M in Q4 2020. 41 funds tracked by Wall St. Rank hold IPOD.WS as of Q1 2021.
- Empyrean Capital Partners reported no remaining Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2021 after selling out during the quarter.
- Empyrean Capital Partners sold 375,000 Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2021, an estimated $1.39M.
- Empyrean Capital Partners first reported a position in Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2020 and held it in 1 quarter.
- Empyrean Capital Partners's Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $1.39M in Q4 2020.
- 41 funds tracked by Wall St. Rank held Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2021.
Based on Empyrean Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.